BIM
ARRY

BlackRock Investment Management’s Array Biopharma Inc ARRY Stock Holding History

BlackRock Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.94M Buy
675,469
+80,034
+13% +$589K 0.01% 1472
2016
Q3 		$4.02M Buy
595,435
+3,446
+0.6% +$13.3K ﹤0.01% 1636
2016
Q2 		$2.11M Buy
591,989
+104,522
+21% +$341K ﹤0.01% 2056
2016
Q1 		$1.44M Buy
487,467
+7,856
+2% +$23.5K ﹤0.01% 2221
2015
Q4 		$2.02M Sell
479,611
-57
-0% -$260 ﹤0.01% 2075
2015
Q3 		$2.19M Sell
479,668
-7,487
-2% -$44.4K ﹤0.01% 2016
2015
Q2 		$3.51M Buy
487,155
+68,904
+16% +$508K ﹤0.01% 1775
2015
Q1 		$3.08M Buy
418,251
+46,309
+12% +$330K ﹤0.01% 1726
2014
Q4 		$1.76M Sell
371,942
-7,074
-2% -$28K ﹤0.01% 2123
2014
Q3 		$1.35M Buy
379,016
+2,522
+0.7% +$9.94K ﹤0.01% 2295
2014
Q2 		$1.72M Buy
376,494
+33,414
+10% +$138K ﹤0.01% 2202
2014
Q1 		$1.61M Buy
343,080
+5,276
+2% +$26.5K ﹤0.01% 2182
2013
Q4 		$1.69M Buy
337,804
+6,800
+2% +$37K ﹤0.01% 2144
2013
Q3 		$2.06M Buy
331,004
+20,313
+7% +$121K ﹤0.01% 1938
2013
Q2 		$1.41M Buy
+310,691
New +$1.67M ﹤0.01% 2125

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

BlackRock Investment Management's ARRY Position: Q4 2016 in Review

BlackRock Investment Management increased its Array Biopharma Inc (ARRY) stake by 13% in Q4 2016, buying an estimated $589K and bringing the position to 675,469 shares worth $5.94M. The position accounts for 0.01% of the portfolio, ranked #1472.

BlackRock Investment Management first reported a position in ARRY in Q2 2013 and has held it in 15 quarters since. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • BlackRock Investment Management held 675,469 shares of Array Biopharma Inc worth $5.94M as of Q4 2016.
  • BlackRock Investment Management bought 80,034 Array Biopharma Inc shares in Q4 2016, an estimated $589K.
  • Array Biopharma Inc made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1472 holding.
  • BlackRock Investment Management first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 15 quarters since.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.